SKN | Prenetics Boosts Bitcoin Holdings With $11 Million Buy as Wellness Unit IM8 Tops $100 Million in Annual Revenue

Key Points:

• Prenetics (NASDAQ: PRE) purchased 100 BTC for $11 million, expanding total holdings to 378 BTC worth about $41 million.

• The company’s wellness brand IM8 surpassed $100 million ARR in under a year, marking record growth in the supplement sector.

• Prenetics now holds $127 million in liquidity, no debt, and aims to reach $1 billion in both revenue and Bitcoin holdings within five years.

Prenetics Global Limited (NASDAQ: PRE) has expanded its Bitcoin treasury holdings by purchasing an additional 100 BTC for $11 million, reinforcing its position as one of the few publicly listed healthcare firms integrating cryptocurrency into its corporate strategy. The move comes as Prenetics’ wellness brand IM8 surpassed $100 million in annual recurring revenue (ARR) in less than a year — signaling strong growth in both the company’s core business and its digital asset strategy.

The Hong Kong-based company now holds 378 BTC, valued at approximately $41 million, alongside $86 million in cash, bringing total liquidity to $127 million with no debt. The new purchase was executed at an average price of $109,594 per BTC, days after completing a $44 million oversubscribed equity offering backed by high-profile investors including Kraken, Exodus, GPTX (Jihan Wu), DL Holdings, XtalPi, and tennis champion Aryna Sabalenka.

Strategic Dual Focus: Health Innovation and Bitcoin Accumulation

In a statement, CEO Danny Yeung described the Bitcoin acquisition as part of the firm’s broader dual mandate — to scale its wellness brand while establishing Bitcoin as a core balance sheet asset.

“This 100 Bitcoin acquisition demonstrates our immediate execution on the strategic vision we outlined to investors,” Yeung said. “We are focused on building IM8 into a global health powerhouse while strengthening our position in Bitcoin as a store of long-term value.”

Prenetics’ Bitcoin accumulation began earlier this year, when it became the first healthcare company to publicly implement a Bitcoin treasury strategy. The firm initially acquired 187.42 BTC worth $20 million at an average cost of $106,712 per coin. Since then, it has followed a disciplined plan of purchasing one Bitcoin per day since August 1, 2025, supplemented by opportunistic larger buys during periods of market weakness.

As of this month, Prenetics’ Bitcoin portfolio represents roughly 32% of its total liquidity, signaling a shift in treasury management strategy that aligns with similar corporate moves by companies like MicroStrategy and Marathon Digital Holdings.

IM8: A Wellness Rocket Fueled by Celebrity and Data

Beyond Bitcoin, Prenetics’ health and wellness division is emerging as a formidable growth engine. Its IM8 supplement brand, co-founded with former footballer David Beckham, has achieved $100 million in ARR within just 11 months, making it one of the fastest-growing brands in the global supplement industry.

IM8’s success lies in its data-driven product development and direct-to-consumer model, which leverages Prenetics’ proprietary health diagnostics platform. The company plans to expand IM8 globally, targeting markets in Southeast Asia, Europe, and North America.

Beckham, who remains a key shareholder and brand ambassador, has cited Prenetics’ health-tech innovation and its collaboration with Professor Dennis Lo — a pioneer in prenatal testing and early cancer detection — as reasons for his continued support.

Bitcoin as a Treasury Asset: Market Context and Strategic Outlook

Prenetics’ decision to hold Bitcoin mirrors a growing corporate trend of using the cryptocurrency as a hedge against currency devaluation and monetary uncertainty. With BTC trading around $109,500 at press time, the company’s holdings are already yielding modest unrealized gains, bolstered by institutional optimism surrounding digital assets.

Market analysts view Prenetics’ move as both strategic and symbolic — positioning the firm at the intersection of health technology and decentralized finance. “Prenetics represents a new wave of companies where innovation in biotech meets financial modernization,” said Eric Lau, an analyst at Galaxy Capital. “Its Bitcoin allocation isn’t speculative; it’s structural.”

Prenetics has also strengthened its governance by appointing former OKEx COO Andy Cheung to its board and engaging advisors from Kraken and TOKEN2049, underscoring a deliberate effort to professionalize its crypto operations.

A Converging Future for Health and Digital Assets

With strong liquidity, a rapidly scaling wellness business, and an expanding Bitcoin treasury, Prenetics is positioning itself as a hybrid growth company — one that bridges physical health and digital value.

The company’s five-year roadmap targets $1 billion in annual revenue and $1 billion in Bitcoin holdings, a goal that, if achieved, could make Prenetics a defining case study in how non-financial enterprises integrate blockchain assets into long-term strategy.

As Bitcoin continues to mature as a corporate reserve asset, Prenetics’ dual focus — science and sound money — could inspire a new blueprint for innovation-driven firms navigating the digital economy’s next decade.